116078-65-0
116078-65-0 結(jié)構(gòu)式
基本信息
Bidisomida
Bidisomide
Bidisomidum
Brn 6536016
Bidisomidum [inn-latin]
Bidisomida [inn-spanish]
(αR)-α-[2-(Acetylisopropylamino)ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide
(αS)-α-[2-(Acetylisopropylamino)ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide
(S)-α-[2-[Acetyl(isopropyl)amino]ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/12/22 | HY-U00232 | 比地索胺 Bidisomide | 116078-65-0 | 1 mg | 1438元 |
| 2025/12/22 | HY-U00232 | 比地索胺 Bidisomide | 116078-65-0 | 5mg | 3563元 |
| 2025/12/22 | HY-U00232 | 比地索胺 Bidisomide | 116078-65-0 | 10mg | 4963元 |
常見問題列表
The antiarrhythmic effects of Bidisomide, a new class I antiarrhythmic drug is investigated in early-phase ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats. Bidisomide (5 mg/kg) reduces the number of premature ventricular complexes and the incidence of ventricular tachycardia and ventricular fibrillation similarly to Mexiletine (MXT) and Disopyramide (DSP) in rats with ventricular arrhythmias induced by coronary artery occlusion. In rats with ventricular arrhythmias induced by coronary artery reperfusion following a 5 min coronary occlusion, the antiarrhythmic effects of 5 mg/kg of Bidisomide are similar to those of the same doses of MXT and DSP. All three drugs significantly slow the heart rate.